Neuronetics

Yahoo Finance • yesterday

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 15 days ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story

Yahoo Finance • 16 days ago

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

MALVERN, Pa., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expe... Full story

Yahoo Finance • 24 days ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

MALVERN, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • last year

Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference

MALVERN, Pa., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • last year

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

MALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • last year

Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage

MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story

Yahoo Finance • last year

Neuronetics Reports Third Quarter 2023 Financial and Operating Results

MALVERN, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wh... Full story

Yahoo Finance • last year

Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who su... Full story

Yahoo Finance • last year

Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes

MALVERN, Pa., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • last year

Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility

MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the b... Full story

Yahoo Finance • last year

In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression

MALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neuroh... Full story

Yahoo Finance • 2 years ago

NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards

MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 2 years ago

Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform

MALVERN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 2 years ago

NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player

MALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 2 years ago

Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy

MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohe... Full story

Yahoo Finance • 2 years ago

Neuronetics Wins 2023 Bell Seal for Workplace Mental Health

MALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohea... Full story

Yahoo Finance • 2 years ago

Neuronetics to Present at the JMP Securities Life Sciences Conference

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wher... Full story

Yahoo Finance • 2 years ago

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wher... Full story

Yahoo Finance • 2 years ago

Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting

MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suf... Full story